Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.

Article  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209.

Article  PubMed  Google Scholar 

World Health Organization. Global Cancer Observatory: Cancer Tomorrow. 2020. Available online at: https://gco.iarc.fr/tomorrow/en/dataviz/isotype. Accessed 25 Mar 2021.

Erkal H, Mendenhall W, Amdur R, Villaret D, Stringer S. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol Off Journal Am Soc Clin Oncol. 2001;19(5):1358–62.

Article  CAS  Google Scholar 

Domingo-Vidal M, Whitaker-Menezes D, Martos-Rus C, Tassone P, Snyder CM, Tuluc M, Philp N, Curry J, Martinez-Outschoorn U. Cigarette smoke induces metabolic reprogramming of the tumor stroma in head and neck squamous cell carcinoma. Mol Cancer Res. 2019;17(9):1893–909.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez-Outschoorn UE, Peiris-Pages M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11–31.

Article  CAS  PubMed  Google Scholar 

Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):5473.

Article  Google Scholar 

Matsushita Y, Nakagawa H, Koike K. Lipid metabolism in oncology: why it matters, how to research, and how to treat. Cancers. 2021;13(3):474.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faubert B, Vincent EE, Griss T, Samborska B, Izreig S, Svensson RU, Mamer OA, Avizonis D, Shackelford DB, Shaw RJ, et al. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1alpha. Proc Natl Acad Sci USA. 2014;111(7):2554–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Svensson RU, Parker SJ, Eichner LJ, Kolar MJ, Wallace M, Brun SN, Lombardo PS, Van Nostrand JL, Hutchins A, Vera L, et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Nat Med. 2016;22(10):1108–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vander Heiden M, Cantley L, Thompson C. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park G, Kim J, Roh J, Choi S, Nam S, Kim S. Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx. Ann Oncol Off J European Soc Med Oncol. 2013;24(1):208–14.

Article  CAS  Google Scholar 

Paidpally V, Chirindel A, Lam S, Agrawal N, Quon H, Subramaniam R. FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging in medicine. 2012;4(6):633–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonomo P, Merlotti A, Olmetto E, Bianchi A, Desideri I, Bacigalupo A, Franco P, Franzese C, Orlandi E, Livi L, et al. What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2018;45(12):2122–38.

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci: CMLS. 2016;73(2):377–92.

Article  CAS  PubMed  Google Scholar 

Voisin M, de Medina P, Mallinger A, Dalenc F, Huc-Claustre E, Leignadier J, Serhan N, Soules R, Ségala G, Mougel A, et al. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor. Proc Natl Acad Sci USA. 2017;114(44):E9346–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu X, Chen J, Li Y, Yang X, Wang Q, Wen Y, Yan M, Zhang J, Xu Q, Wei Y, et al. Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma. Cell Death Dis. 2021;12(5):482.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Song Q, Xia L, Xu X. Synergy of dendritic cell vaccines and avasimibe in treatment of head and neck cancer in mice. Med Sci Monitor Int Med J Exp Clin Res. 2017;23:4471–6.

Google Scholar 

Nakajima E, Laymon C, Oborski M, Hou W, Wang L, Grandis J, Ferris R, Mountz J, Van Houten B. Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions. PLoS ONE. 2014;9(8): e102452.

Article  PubMed  PubMed Central  Google Scholar 

Karasinska J, Topham J, Kalloger S, Jang G, Denroche R, Culibrk L, Williamson L, Wong H, Lee M, O’Kane G, et al. Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer. Clin Cancer Res Off Journal Am Assoc Cancer Res. 2020;26(1):135–46.

Article  CAS  Google Scholar 

Sandulache V, Ow T, Pickering C, Frederick M, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers J. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer. 2011;117(13):2926–38.

Article  CAS  PubMed  Google Scholar 

Rocken C. Molecular classification of gastric cancer. Expert Rev Mol Diagn. 2017;17(3):293–301.

Article  PubMed  Google Scholar 

Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and molecular classification of lung cancer. Cancer Treat Res. 2016;170:25–46.

Article  PubMed  Google Scholar 

Provenzano E, Ulaner G, Chin S. Molecular classification of breast cancer. PET clinics. 2018;13(3):325–38.

Article  PubMed  Google Scholar 

Lohavanichbutr P, Méndez E, Holsinger F, Rue T, Zhang Y, Houck J, Upton M, Futran N, Schwartz S, Wang P, et al. A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation. Clin Cancer Res Off Journal Am Assoc Cancer Res. 2013;19(5):1197–203.

Article  CAS  Google Scholar 

Karasinska JM, Topham JT, Kalloger SE, Jang GH, Denroche RE, Culibrk L, Williamson LM, Wong HL, Lee MKC, O’Kane GM, et al. Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer. Clin Cancer Res. 2020;26(1):135–46.

Article  CAS  PubMed  Google Scholar 

Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov J. Molecular signatures database (MSigDB) 3 0. Bioinformatics. 2011;27(12):1739–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilkerson M, Hayes D. Consensus cluster plus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian S, Meng G, Zhang W. A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma. Cancer Manag Res. 2019;11:131–42.

Article  CAS  PubMed  Google Scholar 

Cao R, Wu Q, Li Q, Yao M, Zhou H. A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma. PeerJ. 2019;7: e7360.

Article  PubMed  PubMed Central  Google Scholar 

Duitama J, Quintero J, Cruz D, Quintero C, Hubmann G, Foulquié-Moreno M, Verstrepen K, Thevelein J, Tohme J. An integrated framework for discovery and genotyping of genomic variants from high-throughput sequencing experiments. Nucleic Acids Res. 2014;42(6): e44.

Article  PubMed  PubMed Central  Google Scholar 

Laddha S, Ganesan S, Chan C, White E. Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol Cancer Res MCR. 2014;12(4):485–90.

Article  CAS  PubMed  Google Scholar 

Remmele W, Stegner H. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8(3):138–40.

CAS  PubMed  Google Scholar 

Wilkie MD, Anaam EA, Lau AS, Rubbi CP, Jones TM, Boyd MT, Vlatkovic N. TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies. Cancer Lett. 2020;478:107–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi S, Ji S, Qin Y, Xu J, Zhang B, Xu W, Liu J, Long J, Liu C, Liu L, et al. Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer. Cancer Lett. 2015;360(2):227–33.

Article  CAS